MetaVia
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.About MTVA
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
MTVA Key Statistics
Stock Snapshot
MetaVia(MTVA) stock is priced at $1.43, giving the company a market capitalization of 7.66M. It carries a P/E multiple of -0.16.
On 2026-04-15, MetaVia(MTVA) stock moved within a range of $1.40 to $1.56. With shares now at $1.43, the stock is trading +2.2% above its intraday low and -8.5% below the session's peak.
Trading activity shows a volume of 112.55K, compared to an average daily volume of 139.78K.
The stock's 52-week range extends from a low of $1.17 to a high of $23.10.
The stock's 52-week range extends from a low of $1.17 to a high of $23.10.
MTVA News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
MetaVia (MTVA) announced that the first patient has been dosed in Part 3 of its Phase 1 clinical trial evaluating DA-1726, a novel dual oxyntomodulin analog tar...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.